Active Ingredient History
Trimethoprim/sulfamethoxazole, sold under the brand name Bactrim among others, is a fixed-dose combination antibiotic medication used to treat a variety of bacterial infections. It consists of one part trimethoprim to five parts sulfamethoxazole. It is used to treat urinary tract infections, methicillin-resistant Staphylococcus aureus (MRSA) skin infections, travelers' diarrhea, respiratory tract infections, and cholera, among others. It is used both to treat and prevent pneumocystis pneumonia and toxoplasmosis in people with HIV/AIDS and other causes of immunosuppression. It can be given by mouth or intravenously. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Bacterial Infections (Phase 3)
Bacteriuria (Phase 2)
Child Development (Phase 4)
COVID-19 (Phase 3)
Fever (Phase 3)
General Surgery (Phase 2)
HIV (Phase 4)
HIV Infections (Phase 4)
Infant, Newborn (Phase 3)
Infections (Phase 2)
Kidney Calculi (Phase 4)
Lung Diseases (Phase 3)
Melioidosis (Phase 4)
Opportunistic Infections (Phase 4)
Peritonitis (Phase 3)
Pneumonia, Pneumocystis (Phase 4)
Pregnancy Complications (Phase 2)
Primary Prevention (Phase 4)
Prostatic Neoplasms (Phase 2)
Prosthesis-Related Infections (Phase 2)
Sepsis (Phase 3)
Sexually Transmitted Diseases (Phase 2)
Tuberculosis (Phase 2)
Urinary Tract Infections (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue